Telomir Pharmaceuticals, INC. (TELO) SEC Filings — 2024

Filings

• Telomir Pharmaceuticals Files 8-K — 8-K · Dec 23, 2024
• Telomir Pharmaceuticals Changes Accountants — 8-K · Dec 20, 2024
• Telomir Pharmaceuticals Sells $500K in Stock — 8-K · Dec 11, 2024
• Telomir Pharmaceuticals Files 8-K — 8-K · Dec 2, 2024
• Telomir Pharmaceuticals Announces Board and Officer Changes — 8-K · Nov 21, 2024
• Telomir Pharmaceuticals Files 8-K — 8-K · Nov 20, 2024
• Telomir Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
• Telomir Pharmaceuticals Enters Material Agreement with 03 Life Sciences — 8-K · Sep 27, 2024
• Telomir Pharmaceuticals Files 8-K — 8-K · Sep 3, 2024
• Telomir Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
• Telomir Pharmaceuticals Changes HQ, Reports Officer Compensation — 8-K · Jun 24, 2024
• Telomir Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Telomir Pharmaceuticals Files 8-K — 8-K · Apr 15, 2024
• Telomir Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Apr 12, 2024
• Telomir Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
• Telomir Pharma Enters Material Agreement — 8-K · Feb 13, 2024
• Telomir Pharmaceuticals Files S-1/A Amendment — S-1/A · Jan 3, 2024